Authors:
REESINK HW
ENGELFRIET CP
VRIELINK H
KRUSIUS T
LANKINEN M
FLANAGAN P
BARBARA J
GILL P
DODD RY
BUSCH MP
PRATI D
MOZZI F
SIRCHIA G
DIEKAMP U
EPSTEIN JS
TABOR E
MARTINVEGA C
HERNANDEZ JM
Citation: Hw. Reesink et al., CONSEQUENCES OF NUCLEIC-ACID AMPLIFICATION TESTING FOR BLOOD-TRANSFUSION CENTERS, Vox sanguinis, 74(4), 1998, pp. 263-270
Citation: Pjm. Vandenburg et al., TIME-INTERVAL OF 5 YEARS BETWEEN HTLV-I INFECTION AND THE APPEARANCE OF ANTIBODIES IN A REPEAT BLOOD-DONOR, Transfusion, 38(10), 1998, pp. 191-191
Citation: Mr. Habibuw et al., EVALUATION OF NUCLEIC-ACID AMPLIFICATION TECHNOLOGY (NAT) EFFICIENCY OF HEPATITIS-C VIRUS (HCV) IN POOL SCREENING SYSTEMS, Transfusion, 38(10), 1998, pp. 206-206
Citation: H. Vrielink et al., THE CLINICAL RELEVANCE OF HTLV TYPE-I AND TYPE-II IN TRANSFUSION MEDICINE, Transfusion medicine reviews, 11(3), 1997, pp. 173-179
Citation: H. Vrielink et Cl. Vanderpoel, WHAT ARE THE CONSEQUENCES OF INDETERMINATE RESULTS IN CONFIRMATORY TESTS FOR ANTIBODIES AGAINST TRANSMISSIBLE VIRUSES, Vox sanguinis, 73(2), 1997, pp. 104-104
Authors:
VRIELINK H
REESINK HW
ZAAIJER HL
SCHOLTEN E
KREMER LCM
CUYPERS HTM
LELIE PN
VANOERS MHJ
VANDERPOEL CL
Citation: H. Vrielink et al., LOOK-BACK OF ANTI-HCV ELISA-POSITIVE, HCV-RNA PCR-NEGATIVE DONORS ANDRECIPIENTS OF THEIR BLOOD PRODUCTS, Vox sanguinis, 72(2), 1997, pp. 67-70
Citation: H. Vrielink et Hw. Reesink, ANALYSIS OF THE SENSITIVITY OF REAGENTS BY TESTING PANELS OF DILUTIONS OF POSITIVE SERA VERSUS PANELS OF WEAKPOSITIVE NATIVE SERA, Transfusion, 37(9), 1997, pp. 103-103
Citation: H. Vrielink et al., EVALUATION OF 3 ANTI-HTLV-I AND ANTI-HTLV-II ASSAYS - ABBOTT, MUREX AND ORGANON-TEKNIKA, Transfusion, 37(9), 1997, pp. 186-186
Authors:
VRIELINK H
REESINK HW
HERMUS MC
CUYPERS HTM
LELIE PN
Citation: H. Vrielink et al., DIFFERENCE IN HGV INFECTION IN BLOOD-DONORS BETWEEN A LARGE CITY AND RURAL DISTRICTS IN A WEST-EUROPEAN COUNTRY, Transfusion, 37(9), 1997, pp. 187-187
Citation: H. Vrielink et al., RELATIVE SENSITIVITY OF 4 ANTI-HTLV-I AND HTLV-II ELISAS - ABBOTT, MUREX, ORGANON-TEKNIKA AND ORTHO, Transfusion, 37(9), 1997, pp. 197-197
Citation: Pjm. Vandenburg et al., HIV WINDOW INFECTION BY AN ANTI-HIV AND HIV-AG NEGATIVE BLOOD PRODUCT- A CASE-REPORT, Transfusion, 37(9), 1997, pp. 212-212
Citation: H. Vrielink et al., PERFORMANCE OF 3 GENERATIONS OF ANTI-HEPATITIS-C VIRUS ENZYME-LINKED IMMUNOSORBENT ASSAYS IN DONORS AND PATIENTS, Transfusion, 37(8), 1997, pp. 845-849
Citation: H. Vrielink et al., SENSITIVITY AND SPECIFICITY OF 4 ASSAYS TO DETECT HUMAN T-LYMPHOTROPIC VIRUS TYPE-I OR TYPE-I II ANTIBODIES/, Transfusion, 36(4), 1996, pp. 344-346
Citation: H. Vrielink et al., NEW SYNTHETIC IMMUNOBLOT FOR CONFIRMATION OF HTLV-I II INFECTION/, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 173-173